Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

CANF | Can-Fite Biopharma Ltd ADR

Index- P/E- EPS (ttm)-3.10 Insider Own- Shs Outstand2.72M Perf Week-7.41%
Market Cap10.20M Forward P/E- EPS next Y-2.58 Insider Trans- Shs Float- Perf Month-9.42%
Income-9.77M PEG- EPS next Q-0.61 Inst Own1.34% Short Float / Ratio- / 1.43 Perf Quarter-17.22%
Sales0.79M P/S12.91 EPS this Y7.26% Inst Trans- Short Interest0.02M Perf Half Y8.70%
Book/sh1.68 P/B1.48 EPS next Y7.54% ROA-75.79% Target Price17.33 Perf Year-66.80%
Cash/sh2.36 P/C1.06 EPS next 5Y- ROE-116.52% 52W Range1.52 - 9.00 Perf YTD-59.22%
Dividend- P/FCF- EPS past 5Y42.38% ROI-141.65% 52W High-72.22% Beta1.31
Dividend %- Quick Ratio4.89 Sales past 5Y56.33% Gross Margin- 52W Low64.47% ATR0.15
Employees- Current Ratio4.89 Sales Q/Q-3.92% Oper. Margin-1280.20% RSI (14)40.55 Volatility5.44% 4.57%
OptionableNo Debt/Eq0.01 EPS Q/Q49.44% Profit Margin-1231.78% Rel Volume0.19 Prev Close2.50
ShortableYes LT Debt/Eq0.00 EarningsAug 31 BMO Payout- Avg Volume10.67K Price2.50
Recom1.00 SMA20-8.63% SMA50-10.30% SMA200-22.37% Volume1,166 Change0.00%
Date Action Analyst Rating Change Price Target Change
Aug-11-17Initiated Maxim Group Buy $7
Oct-19-16Resumed ROTH Capital Buy
Aug-29-16Resumed Rodman & Renshaw Buy $6
Nov-30-15Reiterated H.C. Wainwright Buy $4 → $6
Mar-31-15Reiterated H.C. Wainwright Buy $7 → $3
Mar-30-15Downgrade ROTH Capital Buy → Neutral $20 → $2.40
Dec-29-14Reiterated ROTH Capital Buy $28 → $20
Nov-18-14Initiated H.C. Wainwright Buy $7
Sep-27-23 07:00AM
Sep-07-23 07:00AM
Aug-31-23 07:00AM
Aug-24-23 07:10AM
Aug-18-23 07:00AM
07:00AM Loading…
Aug-08-23 07:00AM
Jul-17-23 07:00AM
Jul-11-23 07:00AM
Jul-07-23 07:00AM
Jun-29-23 07:00AM
Jun-14-23 12:17PM
Jun-13-23 07:00AM
Jun-02-23 07:00AM
Jun-01-23 07:00AM
May-30-23 07:00AM
07:00AM Loading…
May-15-23 07:00AM
May-10-23 12:00PM
May-09-23 07:00AM
May-02-23 07:00AM
Apr-24-23 07:00AM
Apr-10-23 07:00AM
Mar-30-23 07:15AM
Mar-16-23 07:00AM
Mar-13-23 07:00AM
Feb-14-23 07:00AM
Jan-24-23 07:00AM
Jan-11-23 09:04AM
Jan-10-23 07:00AM
Dec-30-22 04:30PM
Dec-29-22 10:18AM
10:21AM Loading…
Dec-28-22 10:21AM
Dec-27-22 08:00AM
Dec-08-22 07:00AM
Nov-25-22 07:00AM
Nov-10-22 02:13PM
Nov-04-22 10:54AM
Nov-02-22 07:15AM
Oct-31-22 09:15AM
Oct-25-22 07:00AM
Oct-13-22 07:00AM
Sep-23-22 08:00AM
Sep-12-22 07:00AM
Aug-25-22 07:00AM
Aug-23-22 07:00AM
Aug-22-22 07:00AM
Aug-17-22 07:25AM
Jul-11-22 07:00AM
Jun-29-22 07:46AM
Jun-24-22 07:00AM
Jun-09-22 07:00AM
May-26-22 07:00AM
May-16-22 07:00AM
May-02-22 07:00AM
Apr-05-22 07:00AM
Mar-28-22 07:00AM
Mar-24-22 08:30AM
Mar-14-22 07:00AM
Mar-11-22 07:00AM
Mar-08-22 08:35AM
Jan-31-22 07:00AM
Jan-13-22 08:44AM
Jan-10-22 07:26AM
Jan-05-22 07:00AM
Dec-30-21 10:58AM
Dec-29-21 10:49AM
Dec-21-21 09:18AM
Dec-20-21 04:05PM
Dec-07-21 07:00AM
Nov-26-21 07:00AM
Nov-24-21 07:00AM
Nov-23-21 07:00AM
Nov-12-21 07:00AM
Nov-01-21 07:00AM
Oct-28-21 07:00AM
Oct-26-21 07:00AM
Oct-21-21 09:25AM
Oct-20-21 10:32AM
Oct-08-21 08:48AM
Oct-05-21 07:00AM
Sep-22-21 07:00AM
Sep-17-21 07:00AM
Sep-09-21 07:00AM
Sep-02-21 07:00AM
Aug-26-21 07:00AM
Aug-12-21 08:00AM
Aug-05-21 09:18AM
Jul-08-21 07:00AM
Jun-28-21 09:11AM
Jun-16-21 07:45AM
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.